Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2013-05-15 | New | $78,500 | $78,500 | Debt Only | 06 | SEC link |
| 2013-02-01 | Amended | $1,315,000 | $0 | Debt Only | 06 | SEC link |
| 2012-10-04 | New | $1,100,000 | $1,100,000 | Debt Only | 06 | SEC link |
| 2012-08-22 | New | $2,944,323 | $2,944,323 | Equity Only | 06 | SEC link |
| 2012-07-18 | Amended | $2,739,500 | $40,000 | Other | 06 | SEC link |
| 2012-01-04 | New | $1,275,000 | $1,275,000 | Other | 06 | SEC link |
| Name | Role |
|---|---|
| Warren Chaunce Bogard | Director |
| Kevin Harter | Director |
| Paula Z. Mac Donald | Director, Executive |
| David Mc Lachlan | Director |
| Thomas Penn | Director |
| Bernard Rudnick | Director |
| Michele Washko | Director |